Shanghai Pioneer Holding (HKSE:01345) Interest Expense : HK$-3 Mil (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Shanghai Pioneer Holding Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Shanghai Pioneer Holding's interest expense for the six months ended in Dec. 2023 was HK$ -1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-3 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Shanghai Pioneer Holding's Operating Income for the six months ended in Dec. 2023 was HK$ 103 Mil. Shanghai Pioneer Holding's Interest Expense for the six months ended in Dec. 2023 was HK$ -1 Mil. Shanghai Pioneer Holding's Interest Coverage for the quarter that ended in Dec. 2023 was 78.37. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shanghai Pioneer Holding Interest Expense Historical Data

The historical data trend for Shanghai Pioneer Holding's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pioneer Holding Interest Expense Chart

Shanghai Pioneer Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-4.44

-1.30

-1.14

-1.91

-2.71

Shanghai Pioneer Holding Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-0.55	-1.21	-0.76	-1.40	-1.31

Shanghai Pioneer Holding Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-3 Mil.

Shanghai Pioneer Holding (HKSE:01345) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shanghai Pioneer Holding's Interest Expense for the six months ended in Dec. 2023 was HK$-1 Mil. Its Operating Income for the six months ended in Dec. 2023 was HK$103 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was HK$14 Mil.

Shanghai Pioneer Holding's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	102.511	/	-1.308
	=	78.37

The higher the ratio, the stronger the company's financial strength is.

Shanghai Pioneer Holding (HKSE:01345) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Shanghai Pioneer Holding Ltd (HKSE:01345) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.15, Lane 88 Wuwei Road, Putuo District, Shanghai, CHN, 200331

Website

http://www.pioneer-pharma.com

Shanghai Pioneer Holding Ltd is an investment holding company. It is engaged in the marketing, promotion, sales, and channel management service for pharmaceutical products and medical devices in China. The company has a portfolio of pharmaceutical products, covering ophthalmology, pain management, cardiovascular, gastroenterology, immunology, gynecology, and other therapeutic areas, and medical devices covering several medical specialties, including ophthalmology, orthopedics, odontology, and wound care. The majority of its revenue derives from the Sales of pharmaceutical products segment. The group operates mainly in PRC.

Executives

Bank Of Communications Trustee Limited	2301 Trustee
Pioneer Pharma (bvi) Co.,ltd	2101 Beneficial owner
Tian Tian Limited	2201 Interest of corporation controlled by you
Li Xinzhou	2202 Interest of your spouse
Wu Qian	2201 Interest of corporation controlled by you

Shanghai Pioneer Holding (HKSE:01345) Headlines

No Headlines